Welcome to our dedicated page for RAD news (Ticker: RAD), a resource for investors and traders seeking the latest updates and insights on RAD stock.
Rite Aid Corporation (NYSE: RAD) operates at the forefront of integrated retail pharmacy and healthcare services, providing prescription medications, wellness programs, and pharmacy benefit management solutions. This page aggregates all official announcements, financial disclosures, and strategic developments from the company.
Access real-time updates on Rite Aid's operational milestones, including earnings reports, regulatory compliance updates, and partnerships with healthcare providers. Investors will find critical filings like 10-Q and 8-K documents alongside analyses of market positioning against competitors like CVS Health and Walgreens.
The repository covers expansions in telehealth services, PBM contract renewals, and community health initiatives. Content is curated to meet the needs of stakeholders requiring timely, accurate information for decision-making.
Bookmark this page for streamlined tracking of Rite Aid's evolving role in retail healthcare. Check regularly for updates on store network changes, leadership announcements, and responses to industry trends like digital health adoption.
Bartell Drugs has partnered with Uber Technologies (NYSE: UBER) to enhance on-demand delivery services in the Puget Sound region. Customers can now order healthcare and grocery products from all 67 Bartell's locations via Uber Eats. This initiative ensures quick delivery and includes perks for Uber Pass and Eats Pass subscribers, such as $0 delivery on certain orders. This partnership aligns with Uber's strategy to provide convenience in shopping, reinforcing its goal to facilitate access to essential products for consumers. Bartell Drugs is owned by Rite Aid Corporation, which also expands its delivery network with Uber.
Rite Aid (NYSE: RAD) has expanded its partnership with Uber Technologies, Inc. (NYSE: UBER) to provide nationwide delivery of Rite Aid products via Uber Eats. This initiative allows customers to order essential healthcare and grocery items from 2,185 Rite Aid locations across 17 states. The service features no delivery fees for Uber Pass and Eats Pass holders, in addition to discounts on orders over $15. This collaboration aims to enhance customer convenience and reflects changing consumer shopping habits.
Rite Aid reported a 2.2% increase in revenues from continuing operations, reaching $6.11 billion for the second quarter. However, the company faced a substantial net loss of $100.3 million or $1.86 per share, compared to the previous year’s loss of $13.2 million. Adjusted net loss stood at $22 million with adjusted EBITDA at $106.2 million, down from $151.6 million a year prior. The company has improved its financial flexibility by amending its credit agreement, extending its debt maturity to 2026. Looking ahead, Rite Aid raised its fiscal 2022 adjusted EBITDA guidance.
Rite Aid (NYSE: RAD) has partnered with CLEAR (NYSE: YOU) to provide customers with a secure digital vaccine card for COVID-19 vaccinations. Customers can easily access this card via CLEAR’s app after receiving their vaccinations at Rite Aid locations. This initiative aims to facilitate proof of vaccination for various activities, particularly as requirements increase across states and businesses. Rite Aid has administered over seven million vaccinations, showcasing its commitment to community health.
Rite Aid (NYSE: RAD) announced a new corporate headquarters in
Elixir, a subsidiary of Rite Aid (NYSE: RAD), has appointed Lance Neill as its new Chief Operating Officer. Neill brings extensive experience from his previous roles, including Vice President of Network Development at Centene, managing a $32 billion pharmacy spend. He will oversee core operations and strategic development at Elixir. CEO Heyward Donigan emphasized Elixir's importance in Rite Aid's growth strategy, highlighting Neill's qualifications to enhance operational excellence and strategic priorities.
Rite Aid Corporation (NYSE:RAD) will announce its Fiscal 2022 Second Quarter financial results on September 23, 2021, following the quarter ending August 28, 2021. An analyst call will take place at 8:30 a.m. Eastern Time, featuring comments from the management team. The call will be available via webcast, with a replay accessible at Rite Aid's Investor Relations page. Additionally, a telephone replay will be available from 12:00 p.m. ET on September 23 until 11:59 p.m. ET on October 24.
Rite Aid (NYSE: RAD) and BioReference, an OPKO Health company (NASDAQ: OPK), will provide free COVID-19 testing for New York State public school students ahead of the 2021-2022 school year. This ‘Back to School’ program allows students aged 4-17 to access RT-PCR tests at 115 Rite Aid drive-thru locations. Testing is voluntary, with results delivered digitally to parents. Governor Kathy Hochul emphasized the program's importance in combating the Delta variant and ensuring safe school environments. The initiative aligns with federal efforts to expand school testing.
Rite Aid Corporation (NYSE: RAD) announced an amendment to its senior secured credit agreement, introducing a $2.8 billion asset-based revolving credit facility and a $350 million first-in, last-out senior secured term loan. These amended facilities extend debt maturity to August 2026, providing improved pricing for the term loan. The interest rates on the new facilities are lower than previous rates, signaling confidence from the financial community and supporting Rite Aid's strategic objectives under its RxEvolution strategy.
Rite Aid (NYSE: RAD) has announced the availability of flu vaccines at all its stores, alongside an expanded COVID-19 online scheduling tool for flu and ancillary vaccinations. This initiative aims to simplify the vaccination process as CDC warns of increased flu infection rates. Rite Aid offers various flu vaccination options, including quadrivalent and high-dose vaccines for those aged 65 and older. The online scheduling system allows customers to book appointments easily while ensuring a seamless healthcare experience, part of Rite Aid's RxEvolution strategy.
